Explore

Trendline Trendline
Optimum Communications Restructures to Address Massive Debt Challenges

Optimum Communications Restructures to Address Massive Debt Challenges

Optimum Communications Restructures to Address Massive Debt Challenges
Trendline Trendline
Eli Lilly Partners with Haisco in $3 Billion Deal for Early-Stage Drug Development

Eli Lilly Partners with Haisco in $3 Billion Deal for Early-Stage Drug Development

Eli Lilly Partners with Haisco in $3 Billion Deal for Early-Stage Drug Development
Trendline Trendline
hVIVO Partners with Decoy Therapeutics for Antiviral Development Consultancy

hVIVO Partners with Decoy Therapeutics for Antiviral Development Consultancy

hVIVO Partners with Decoy Therapeutics for Antiviral Development Consultancy
Trendline Trendline
Eli Lilly Partners with Ascidian Therapeutics for $1.9 Billion RNA Exon Editing Deal Targeting Kidney Diseases

Eli Lilly Partners with Ascidian Therapeutics for $1.9 Billion RNA Exon Editing Deal Targeting Kidney Diseases

Eli Lilly Partners with Ascidian Therapeutics for $1.9 Billion RNA Exon Editing Deal Targeting Kidney Diseases
Trendline Trendline
Cocrystal Pharma Appoints James Sapirstein as CEO to Drive Antiviral Development

Cocrystal Pharma Appoints James Sapirstein as CEO to Drive Antiviral Development

Cocrystal Pharma Appoints James Sapirstein as CEO to Drive Antiviral Development
Trendline Trendline
Guitar Center Sells Headquarters in Strategic Sale-Leaseback Deal

Guitar Center Sells Headquarters in Strategic Sale-Leaseback Deal

Guitar Center Sells Headquarters in Strategic Sale-Leaseback Deal
Trendline Trendline
Optimum Communications Initiates Financial Restructuring Amid Debt Challenges

Optimum Communications Initiates Financial Restructuring Amid Debt Challenges

Optimum Communications Initiates Financial Restructuring Amid Debt Challenges
Trendline Trendline
Rallybio and Avenzo Therapeutics Announce Merger to Advance Oncology Therapies

Rallybio and Avenzo Therapeutics Announce Merger to Advance Oncology Therapies

Rallybio and Avenzo Therapeutics Announce Merger to Advance Oncology Therapies
Trendline Trendline
Gossamer Bio Faces Class Action Lawsuit Over Alleged Misleading Trial Disclosures

Gossamer Bio Faces Class Action Lawsuit Over Alleged Misleading Trial Disclosures

Gossamer Bio Faces Class Action Lawsuit Over Alleged Misleading Trial Disclosures
Trendline Trendline
Decoy Therapeutics Partners with hVIVO to Advance Antiviral Candidate into Clinical Trials

Decoy Therapeutics Partners with hVIVO to Advance Antiviral Candidate into Clinical Trials

Decoy Therapeutics Partners with hVIVO to Advance Antiviral Candidate into Clinical Trials
Trendline Trendline
Strategy Sells $2.5 Million in Bitcoin Amid Market Uncertainty, Shares Drop

Strategy Sells $2.5 Million in Bitcoin Amid Market Uncertainty, Shares Drop

Strategy Sells $2.5 Million in Bitcoin Amid Market Uncertainty, Shares Drop
Trendline Trendline
hVIVO Partners with Decoy Therapeutics for Antiviral Development

hVIVO Partners with Decoy Therapeutics for Antiviral Development

hVIVO Partners with Decoy Therapeutics for Antiviral Development